SEC Form 4 · accession 0001787403-26-000002
Elicio Therapeutics, Inc. · ELTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Preetam Shah
Officer — See Remarks
Period of report
Jul 16, 2026
Accepted (ET)
Jul 17, 2026 · 4:13 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001601485
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $3.20 | Jul 16, 2026 | A | 60,833 | A | — | Jul 16, 2036 | Common Stock | 60,833 | 60,833 | D |
Explanation of responses
- F1The stock option vests and becomes exercisable as to 50% of the options on July 16, 2027, the first anniversary of the grant date, and as to the remaining 50% of the options on July 16, 2028, the second anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
Remarks
Chief Strategy and Financial Officer